Management Team

Gene Cartwright – Chief Executive Officer

Mr. Cartwright was appointed CEO in January 2014. He brings over 30 years of experience working in the In vitro diagnostics industry. He joins Guided Therapeutics from Omnyx, LLC, a Joint Venture between GE Healthcare and the University of Pittsburgh Medical Center, where, as CEO for over four years he founded and managed the successful development of products for the field of Digital Pathology. Prior to his work with Omnyx, LLC, he was President of Molecular Diagnostics for GE Healthcare. Before joining GE, he was Divisional Vice President/General Manager for Abbott Diagnostics’ Molecular Diagnostics business. In his 24 year career at Abbott, he also served as Divisional Vice President for U.S. Marketing for five years. He received a Masters of Management degree from Northwestern’s Kellogg School of Management and also holds a Ph.D. in chemistry from Stanford University and an AB from Dartmouth College.

Mark L. Faupel, Ph.D. – Chief Operating Officer

Dr. Faupel currently serves as COO and Secretary of the Company, which he co-founded in 2008.  He previously served on the Company’s board of directors through 2013 and has more than 30 years of experience in developing non-invasive alternatives to surgical biopsies and blood tests, especially in the area of cancer screening and diagnostics. Dr. Faupel served as the Company’s Chief Executive Officer from May 2007 through 2013. Prior thereto was the Company’s Chief Technical Officer from April 2001 to May 2007. Dr. Faupel has served as a National Institutes of Health reviewer, is the inventor on 20 U.S. patents and has authored numerous scientific publications and presentations, appearing in such peer-reviewed journals as The Lancet. Dr. Faupel earned his Ph.D. in neuroanatomy and physiology from the University of Georgia.

Richard L. Fowler – Sr. Vice-president, Engineering

Mr. Fowler is responsible for identifying new technical and business opportunities for Guided Therapeutics. These opportunities include new technologies, product lines or business acquisitions that are strategic to the Company’s business. Mr. Fowler was formerly VP of Engineering at Guided Therapeutics where he oversaw the successful development of the BiliChek®Non-invasive Bilirubin Analyzer.

Mr. Fowler has more than 20 years experience in developing and bringing to market electro-optical devices. Prior to joining Guided Therapeutics, Mr. Fowler was President of Laser Atlanta Optics, Inc. where he developed and launched a new, low-cost laser range finder. He has also held management positions with GEC Avionics, Inc. and General Dynamics. Mr. Fowler holds a degree in Electrical Engineering from the University of Texas.